Curanex Pharmaceuticals Inc - COM (CURX)

CUSIP: 23126K106

Q1 2026 13F Holders as of 31 Mar 2026

Share change
-97,368
SEC-reported price per share
$0.51
Indexed holders
8
Value change
-$19,287
Number of buys
4
Number of sells
9

Security key

23126K106

Report period

Q1 2026

Indexed institutions

8

Top holders

7

Ownership snapshot

Top reported holders of CURX - Curanex Pharmaceuticals Inc - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Dian Ying Jing
Disclosed value leader
CITADEL ADVISORS LLC
Comparable rows
0/14
Latest evidence
31 Dec 2025
3/4/5 13F Highest disclosed value: $34,474 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

CITADEL ADVISORS LLC has the largest disclosed position value at $34.5K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CITADEL ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
CITADEL ADVISORS LLC $34.5K
DRW Securities, LLC $23.7K
TWO SIGMA INVESTMENTS, LP $20.2K
RENAISSANCE TECHNOLOGIES LLC $19.6K
XTX Topco Ltd $14K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Dian Ying Jing
3/4/5
Secretary, 10%+ Owner
—
mixed-class rows
—
11,014,560 shares
mixed-class rows
— 25 Aug 2025
Jun Liu
3/4/5
CEO and President, Director, 10%+ Owner
—
mixed-class rows
—
8,678,760 shares
mixed-class rows
— 25 Aug 2025
Chang Liu
3/4/5
10%+ Owner
—
mixed-class rows
—
5,952,220 shares
mixed-class rows
— 25 Aug 2025
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$34,474
104,278 shares
— 31 Dec 2025
DRW Securities, LLC
13F
Company
13F
—
denominator unverified
$23,655
71,553 shares
— 31 Dec 2025
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$20,200
61,102 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
8
Shares
327,761
Indexed holders
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 indexed holders
11
Q1 2026 indexed holders
8
Indexed holder difference
-3
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .